Back to list

Camber

AI-driven revenue-cycle management and claims automation for specialty-care clinics.
Camber builds revenue-cycle infrastructure for specialty-care providers, automating the insurance-claims lifecycle — eligibility checks, claim creation, pre-submission scrubbing, denial management, appeals and payment posting — for clinics in applied behavior analysis (ABA), physical therapy, speech-language pathology and ENT/allergy. Its rules engine is trained on more than $2.5B in real claims data across its provider network, so each denial produces a payer-specific rule that improves subsequent claims, with human insurance specialists handling escalations and edge cases. The company was founded in 2021 as Juniper (Y Combinator Winter 2021), grew out of an ABA clinic run as a proof of concept, and rebranded to Camber in 2025. It came out of stealth in February 2025 alongside a $30M Series B led by Andreessen Horowitz, disclosing $50M raised to date, 90,000 patients billed for across 42 states, roughly $2B in annual billables under management and a 93% first-pass paid rate. It reports 500+ providers served and a 95%+ first-pass paid rate as of 2026, and has said it intends to expand into home health, long-term care and substance-use-disorder care.
Healthcare 📍 New York, NY Founded 2021
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is Camber going public?
No. Camber is private and has not filed to go public. There is no S-1 on file.
What is Camber's valuation in 2026?
No confirmed valuation is on record for Camber. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Camber filed an S-1?
No public S-1 is on file for Camber.
Who are Camber's investors?
Camber's investors include Andreessen Horowitz, Craft Ventures, ACME, Y Combinator, K Ventures, Manresa.
How much has Camber raised?
Camber has raised $50M in total across 4 disclosed rounds, most recently a Series B of $30M in Feb 2025.
Is Camber publicly traded — can you buy Camber stock?
No. Camber is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Camber on its Pre-IPO Access Desk.
How to actually get exposure to Camber →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Christophe Rimann
Founded
2021
HQ
New York, NY
Employees
85
Total Raised
$50M
Growth
Scaled from a single ABA clinic to billing for 90,000 patients across 42 states and ~$2B in annual billables; claims data trained on has grown to $2.5B+ and headcount to ~85
Last Round
Series B — $30M (Feb 2025) · Lead: Andreessen Horowitz
IPO Status
private

Fundraising Status

Series B · $30M · 1y 7mo ago
privateTotal raised $50M4 disclosed rounds

Growth & Valuation

Capital raised per round
Capital raised per funding round$125KPre-Seed$3MSeed$30MSeries B
Charts built from publicly disclosed funding rounds and revenue estimates. Approximate, not real-time, not investment advice.

Funding History

RoundAmountDateLead InvestorPost-Money
Series B$30MFeb 2025Andreessen Horowitz
Seed$3MMay 2021Craft Ventures
Pre-Seed$125,000Mar 2021Y Combinator
Series AAndreessen Horowitz

Talent Signal

Hiring trend
Hiring uptrend
+15% vs 2026-08
Open roles
15
via ashby
Product-build share
53%
engineering, research, product, design
Trajectory
scaling
product-led hiring — 53% of open roles build product; the rest are go-to-market and G&A.
Executive bench growing while hiring expands: 1 senior hire (CFO); open roles trending up.
Open roles by month
Open roles by month13Aug '2615Sep '26
Open roles by function
Open roles by functionEngineering5Ops & People4Other2Clinical & Science1Data & ML1Design1Sales & GTM1
product-building   go-to-market / G&A
Key Executive Moves
INPeter CoatsCFO · 2026-09-02
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Senior Software Engineer, DataSenior Software EngineerMedical Billing Specialist (ABA)Staff Software EngineerSenior Data EngineerSoftware Engineer
Counted from Camber's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Christophe RimannCelina QiNathan Lee

Investors

Andreessen Horowitz · Craft Ventures · ACME · Y Combinator · K Ventures · Manresa

Products

  • Revenue cycle management platform for specialty-care clinics
  • Camber Rules Engine (payer-specific claim scrubbing and denial prediction)
  • Claims creation, pre-submission scrub and electronic submission
  • Denial management and appeals automation
  • Payment posting and reconciliation
  • Eligibility and prior-authorization verification
  • Revenue analytics and payer-contract benchmarking

Competitors

Candid Health · Adonis · Waystar · CentralReach · Availity
HealthcareRevenue Cycle ManagementHealth ITAIBehavioral Healtha16z-backedY Combinator
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.